“The study of rare diseases of neurodevelopmental disorders and cognitive impairments advances our understanding of underlying mechanisms of disease pathogenesis and lays the foundation for the design of novel therapeutics.”
- Dr. Arezu Jahani-Asl, Associate Professor, Department of Cellular and Molecular Medicine, uOttawa; Affiliate Investigator, The Ottawa Hospital; uOBMRI
- Dr. Arezu Jahani-Asl, Associate Professor, Department of Cellular and Molecular Medicine, uOttawa; Affiliate Investigator, The Ottawa Hospital; uOBMRI
uOBMRI’s Dr. Arezu Jahani-Asl and first-author Dilan Rasool’s publication shines new light on the ultra-rare neurodevelopmental disorder Borjeson-Forssman-Lehmann Syndrome.
Read more about their important findings in this article from the Faculty of Medicine, or read the publication in EMBO Reports here.